ACE and Hypertension: Most (49%) people with new-onset hypertension were initially prescribed a single antihypertensive agent; most commonly angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) (47.8%, N = 106).